sFlt-1

The treatment is designed to reduce a specific circulating placental factor. The preview implies that sFlt-1 is a disease-relevant treatment target rather than only a biomarker. sFlt-1 is described as a placental protein. The reported treatment selectively removes sFlt-1 in preterm pre-eclampsia.